A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma

Robert M W Hofstra, Olimpia Fattoruso, Loredana Quadro, Ying Wu, Alfonso Libroia, Uberta Verga, Vittorio Colantuoni, Charles H C M Buys

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Specific mutations in the ret protooncogene have been found associated with multiple endocrine neoplasia type 2A (MEN 2A) and type 2B (MEN 2B) and familial medullary thyroid carcinoma (FMTC). Mutations in one of five cysteine residues in the extracellular domain have been found in over 95% of families with MEN 2A and 88% of families with FMTC. In MEN 2B patients, a specific mutation at codon 918, substituting a threonine for a methionine, has been found in 95% of cases. In FMTC, in addition to the mutations of the extracellular cysteines, three intracellular base pair changes have been reported at codons 768 and 804. Here we describe a novel intracellular mutation in exon 15 of the ret gene that leads to the substitution of an alanine for a serine at codon 891 in a family with medullary thyroid carcinoma. This amino acid change may be important in determining substrate specificity or, alternatively, may play a role in ATP binding.

Original languageEnglish
Pages (from-to)4176-4178
Number of pages3
JournalJournal of Clinical Endocrinology and Metabolism
Volume82
Issue number12
Publication statusPublished - 1997

Fingerprint

Point Mutation
Cysteine
Multiple Endocrine Neoplasia Type 2b
Mutation
Codon
Multiple Endocrine Neoplasia Type 2a
Threonine
Alanine
Methionine
Serine
Exons
Substitution reactions
Genes
Adenosine Triphosphate
Amino Acids
Substrates
Substrate Specificity
Base Pairing
Medullary Thyroid cancer
Familial medullary thyroid carcinoma

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Hofstra, R. M. W., Fattoruso, O., Quadro, L., Wu, Y., Libroia, A., Verga, U., ... Buys, C. H. C. M. (1997). A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 82(12), 4176-4178.

A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma. / Hofstra, Robert M W; Fattoruso, Olimpia; Quadro, Loredana; Wu, Ying; Libroia, Alfonso; Verga, Uberta; Colantuoni, Vittorio; Buys, Charles H C M.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 82, No. 12, 1997, p. 4176-4178.

Research output: Contribution to journalArticle

Hofstra, RMW, Fattoruso, O, Quadro, L, Wu, Y, Libroia, A, Verga, U, Colantuoni, V & Buys, CHCM 1997, 'A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma', Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 12, pp. 4176-4178.
Hofstra, Robert M W ; Fattoruso, Olimpia ; Quadro, Loredana ; Wu, Ying ; Libroia, Alfonso ; Verga, Uberta ; Colantuoni, Vittorio ; Buys, Charles H C M. / A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma. In: Journal of Clinical Endocrinology and Metabolism. 1997 ; Vol. 82, No. 12. pp. 4176-4178.
@article{629c1bd7f9d94e5fadb61be4fc6a2989,
title = "A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma",
abstract = "Specific mutations in the ret protooncogene have been found associated with multiple endocrine neoplasia type 2A (MEN 2A) and type 2B (MEN 2B) and familial medullary thyroid carcinoma (FMTC). Mutations in one of five cysteine residues in the extracellular domain have been found in over 95{\%} of families with MEN 2A and 88{\%} of families with FMTC. In MEN 2B patients, a specific mutation at codon 918, substituting a threonine for a methionine, has been found in 95{\%} of cases. In FMTC, in addition to the mutations of the extracellular cysteines, three intracellular base pair changes have been reported at codons 768 and 804. Here we describe a novel intracellular mutation in exon 15 of the ret gene that leads to the substitution of an alanine for a serine at codon 891 in a family with medullary thyroid carcinoma. This amino acid change may be important in determining substrate specificity or, alternatively, may play a role in ATP binding.",
author = "Hofstra, {Robert M W} and Olimpia Fattoruso and Loredana Quadro and Ying Wu and Alfonso Libroia and Uberta Verga and Vittorio Colantuoni and Buys, {Charles H C M}",
year = "1997",
language = "English",
volume = "82",
pages = "4176--4178",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "12",

}

TY - JOUR

T1 - A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma

AU - Hofstra, Robert M W

AU - Fattoruso, Olimpia

AU - Quadro, Loredana

AU - Wu, Ying

AU - Libroia, Alfonso

AU - Verga, Uberta

AU - Colantuoni, Vittorio

AU - Buys, Charles H C M

PY - 1997

Y1 - 1997

N2 - Specific mutations in the ret protooncogene have been found associated with multiple endocrine neoplasia type 2A (MEN 2A) and type 2B (MEN 2B) and familial medullary thyroid carcinoma (FMTC). Mutations in one of five cysteine residues in the extracellular domain have been found in over 95% of families with MEN 2A and 88% of families with FMTC. In MEN 2B patients, a specific mutation at codon 918, substituting a threonine for a methionine, has been found in 95% of cases. In FMTC, in addition to the mutations of the extracellular cysteines, three intracellular base pair changes have been reported at codons 768 and 804. Here we describe a novel intracellular mutation in exon 15 of the ret gene that leads to the substitution of an alanine for a serine at codon 891 in a family with medullary thyroid carcinoma. This amino acid change may be important in determining substrate specificity or, alternatively, may play a role in ATP binding.

AB - Specific mutations in the ret protooncogene have been found associated with multiple endocrine neoplasia type 2A (MEN 2A) and type 2B (MEN 2B) and familial medullary thyroid carcinoma (FMTC). Mutations in one of five cysteine residues in the extracellular domain have been found in over 95% of families with MEN 2A and 88% of families with FMTC. In MEN 2B patients, a specific mutation at codon 918, substituting a threonine for a methionine, has been found in 95% of cases. In FMTC, in addition to the mutations of the extracellular cysteines, three intracellular base pair changes have been reported at codons 768 and 804. Here we describe a novel intracellular mutation in exon 15 of the ret gene that leads to the substitution of an alanine for a serine at codon 891 in a family with medullary thyroid carcinoma. This amino acid change may be important in determining substrate specificity or, alternatively, may play a role in ATP binding.

UR - http://www.scopus.com/inward/record.url?scp=0030819689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030819689&partnerID=8YFLogxK

M3 - Article

C2 - 9398735

AN - SCOPUS:0030819689

VL - 82

SP - 4176

EP - 4178

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 12

ER -